Validating the rationale of our screen, knockdown of PTBP1 suppresses the tumor-promoting effects of the SASP without reverting growth arrest in a preclinical model of advanced liver cancer, suggesting that SASP modulation can be a safe way to target inflammation-driven cancers. This evidence concerns the gene PTBP1 and cancer.